Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study.
Katharina KolbeIvonne HaffnerKatrin SchierleDieter MaierBirgitta GeierBirgit LuberHendrik BläkerChristian WittekindFlorian LordickPublished in: Journal of cancer research and clinical oncology (2022)
Tumor localization and histological subtype have an impact on HER2 test deviation rates. Assessment of HER2 remains challenging for GC and EGJC.
Keyphrases